Current Report Filing (8-k)
09 12월 2015 - 8:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
December
8, 2015
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
0-21116
|
|
87-0500306
|
(Commission File No.)
|
|
(IRS Employer Identification
|
|
|
Number)
|
3838 West Parkway Boulevard Salt Lake City, Utah 84120
|
(Address
of principal executive offices, Zip
Code)
|
Registrant’s
telephone number, including area code: (801)
954-7100
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other Events.
On December 8, 2015, USANA Health Sciences, Inc. (the “Company”), issued
a press release announcing that its Board of Directors has authorized an
additional $100 million in funding for share repurchases by the Company
of its outstanding common stock. The Company also disclosed in the
release that, as of December 4, 2015, the Company has repurchased
approximately 456,790 shares during the fourth quarter of 2015 for a
total investment of $61.2 million, which completes the Board of
Directors’ previous share repurchase authorization. A copy of the press
release is furnished herewith as Exhibit 99 to this Current Report on
Form 8-K and is incorporated herein by reference. The Company will also
post the press release, along with this Form 8-K, on its corporate
website, www.usanahealthsciences.com.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99 Press release issued by USANA Health Sciences, Inc.
dated December 8, 2015 (furnished herewith).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
By: /s/ Paul A. Jones
|
|
|
|
|
|
Paul A. Jones, Chief Financial Officer
|
|
|
|
Date:
|
December 8, 2015
|
|
Exhibit 99
USANA
Health Sciences Increases Share Repurchase Authorization by $100 Million
SALT LAKE CITY--(BUSINESS WIRE)--December 8, 2015--USANA Health
Sciences, Inc. (NYSE: USNA) today announced that its Board of Directors
has authorized an additional $100 million in funding for share
repurchases by the Company of its outstanding common stock. As of
December 4, 2015, the Company has repurchased approximately 456,790
shares during the fourth quarter of 2015 for a total investment of $61.2
million, which completes the Board of Directors’ previous share
repurchase authorization.
Repurchases may be made from time to time, in the open market, through
block trades or otherwise. The number of shares to be purchased and the
timing of purchases will be based on market conditions, the level of
cash balances, general business opportunities, and other factors.
About USANA
USANA develops and manufactures high-quality nutritional supplements,
healthy foods and personal care products that are sold directly to
Associates and Preferred Customers throughout the United States, Canada,
Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea,
Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the
United Kingdom, Thailand, France, Belgium, Colombia and Indonesia. More
information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Our actual results could differ materially from
those projected in these forward-looking statements, which involve a
number of risks and uncertainties, including global economic conditions
generally, reliance upon our network of independent Associates, the
governmental regulation of our products, manufacturing and marketing
risks, adverse publicity risks, and risks associated with our
international expansion. The contents of this release should be
considered in conjunction with the risk factors, warnings, and
cautionary statements that are contained in our most recent filings with
the Securities and Exchange Commission.
CONTACT:
USANA Health Sciences, Inc.
Investors contact:
Patrique
Richards, 801-954-7961
Investor Relations
investor.relations@us.usana.com
or
Media
contact:
Dan Macuga, 801-954-7280
Public Relations
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024